334 related articles for article (PubMed ID: 20519943)
1. Transcriptional crosstalk between TGF-β and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes.
Fuxe J; Vincent T; Garcia de Herreros A
Cell Cycle; 2010 Jun; 9(12):2363-74. PubMed ID: 20519943
[TBL] [Abstract][Full Text] [Related]
2. HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition.
Thuault S; Tan EJ; Peinado H; Cano A; Heldin CH; Moustakas A
J Biol Chem; 2008 Nov; 283(48):33437-46. PubMed ID: 18832382
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression.
Saitoh M
Cancer Sci; 2015 May; 106(5):481-8. PubMed ID: 25664423
[TBL] [Abstract][Full Text] [Related]
4. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
5. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
[TBL] [Abstract][Full Text] [Related]
6. Roles of Signaling Pathways in the Epithelial-Mesenchymal Transition in Cancer.
Liu X; Yun F; Shi L; Li ZH; Luo NR; Jia YF
Asian Pac J Cancer Prev; 2015; 16(15):6201-6. PubMed ID: 26434817
[TBL] [Abstract][Full Text] [Related]
7. TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1.
Su J; Morgani SM; David CJ; Wang Q; Er EE; Huang YH; Basnet H; Zou Y; Shu W; Soni RK; Hendrickson RC; Hadjantonakis AK; Massagué J
Nature; 2020 Jan; 577(7791):566-571. PubMed ID: 31915377
[TBL] [Abstract][Full Text] [Related]
8. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
9. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
Katsuno Y; Lamouille S; Derynck R
Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
[TBL] [Abstract][Full Text] [Related]
10. The interplay between TGF-β/SMAD and BMP/SMAD signaling pathways in the epithelial mesenchymal transition of A549 cells induced by silica.
Yu Y; Lin Y; Yang G; Tian L
Toxicol Mech Methods; 2018 May; 28(4):286-292. PubMed ID: 29161937
[TBL] [Abstract][Full Text] [Related]
11. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
Fuxe J; Karlsson MC
Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
[TBL] [Abstract][Full Text] [Related]
12. TGF-β Signaling in Cancer.
Syed V
J Cell Biochem; 2016 Jun; 117(6):1279-87. PubMed ID: 26774024
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
14. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
15. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
16. Alternative splicing in EMT and TGF-β signaling during cancer progression.
Zhang YE; Stuelten CH
Semin Cancer Biol; 2024 Jun; 101():1-11. PubMed ID: 38614376
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer.
Miyazono K
Proc Jpn Acad Ser B Phys Biol Sci; 2009; 85(8):314-23. PubMed ID: 19838011
[TBL] [Abstract][Full Text] [Related]
18. Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway.
Guo Y; Cui W; Pei Y; Xu D
Gynecol Oncol; 2019 Jun; 153(3):639-650. PubMed ID: 30928020
[TBL] [Abstract][Full Text] [Related]
19. The relevance of the TGF-β Paradox to EMT-MET programs.
Morrison CD; Parvani JG; Schiemann WP
Cancer Lett; 2013 Nov; 341(1):30-40. PubMed ID: 23474494
[TBL] [Abstract][Full Text] [Related]
20. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.
Espinoza I; Miele L
Cancer Lett; 2013 Nov; 341(1):41-5. PubMed ID: 23973264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]